Paris-headquartered pharmaceutical giant Sanofi has agreed to divest its Brazilian generics unit, Medley, to local drugmaker EMS, in a move signaling further streamlining of its global portfolio and...
TL;DR
Novo Nordisk entered a partnership with Vivtex Corp. valued at up to $2.1 billion to develop oral medicines for obesity and diabetes. The deal leverages Vivtex's proprietary drug delivery...
TL;DR
GlaxoSmithKline (GSK) acquired Montreal-based 35Pharma Inc. for $950 million in cash, securing HS235, an investigational activin signaling inhibitor. This drug targets pulmonary hypertension,...
TL;DR
Danaher Corporation has agreed to acquire Masimo Corporation for approximately $9.9 billion in an all-cash transaction at $180 per share. The deal, approved by both boards, is expected to...
TL;DR
Humana Inc. is in advanced talks to acquire Sarasota-based primary care network MaxHealth for nearly $1 billion. The deal would bolster Humana's footprint in the critical Florida Medicare...
TL;DR
Eli Lilly announced its acquisition of Orna Therapeutics for up to $2.4 billion in cash on February 9, 2026, gaining access to Orna's circular RNA platform for in vivo cell engineering. The...
TL;DR
Novartis is strategically prioritizing early-stage pipeline assets and clinical-stage candidates for acquisition, a shift driven by intense competition and prohibitive valuations for...
TL;DR
Mubadala Capital has exited its minority stake in Arcadia Consumer Healthcare, with majority owner Bansk Group assuming full control through a continuation vehicle backed by Coller Capital and...
TL;DR
Merck & Co. terminated acquisition talks with Revolution Medicines for a potential $28-32 billion deal, causing Revolution's stock to plunge 20%. The collapse stemmed from a valuation...
TL;DR
BioCryst Pharmaceuticals Inc. completed its all-cash acquisition of Astria Therapeutics Inc. for $700 million on January 23, 2026. This transaction significantly enhances BioCryst's leadership...
